Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Maricic

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Rheumatic Diseases Clinics of North America|October 26, 2011
Update on glucocorticoid-induced osteoporosisMichael Maricic
Current Osteoporosis Reports|April 29, 2010
Intravenous zoledronic acid: what are the indications for male osteoporosis?Michael Maricic
Current Osteoporosis Reports|March 11, 2006
The use of zoledronic acid for Paget's disease of boneMichael Maricic
Current Opinion in Rheumatology|June 7, 2007
New and emerging treatments for osteoporosisMichael Maricic
Menopause (New York, N.Y.)|September 8, 2005
Ethnic variation in bone mineral density: on the road to fracture preventionMichael Maricic
Current Osteoporosis Reports|July 23, 2005
Glucocorticoid-induced osteoporosis: treatment options and guidelinesMichael Maricic
Current Osteoporosis Reports|November 27, 2008
OsteomalaciaMichael Maricic
Clinical Rheumatology|June 15, 2010
The role of zoledronic acid in the management of osteoporosisMichael Maricic
Drugs of Today (Barcelona, Spain : 1998)|January 5, 2008
Zoledronic acid for Paget's disease of boneMichael Maricic
Current Rheumatology Reports|June 19, 2014
Use of DXA-based technology for detection and assessment of risk of vertebral fracture in rheumatology practiceMichael Maricic
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Rheumatic Diseases Clinics of North America|October 26, 2011
Update on glucocorticoid-induced osteoporosisMichael Maricic
Current Osteoporosis Reports|April 29, 2010
Intravenous zoledronic acid: what are the indications for male osteoporosis?Michael Maricic
Current Osteoporosis Reports|March 11, 2006
The use of zoledronic acid for Paget's disease of boneMichael Maricic
Current Opinion in Rheumatology|June 7, 2007
New and emerging treatments for osteoporosisMichael Maricic
Menopause (New York, N.Y.)|September 8, 2005
Ethnic variation in bone mineral density: on the road to fracture preventionMichael Maricic
Current Osteoporosis Reports|July 23, 2005
Glucocorticoid-induced osteoporosis: treatment options and guidelinesMichael Maricic
Current Osteoporosis Reports|November 27, 2008
OsteomalaciaMichael Maricic
Clinical Rheumatology|June 15, 2010
The role of zoledronic acid in the management of osteoporosisMichael Maricic
Drugs of Today (Barcelona, Spain : 1998)|January 5, 2008
Zoledronic acid for Paget's disease of boneMichael Maricic
Current Rheumatology Reports|June 19, 2014
Use of DXA-based technology for detection and assessment of risk of vertebral fracture in rheumatology practiceMichael Maricic
Pageof 3